Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.
Berit Singer, Daniel Meling, Matthias Hirsch-Hoffmann, Lars Michels, Michael Kometer, Lukasz Smigielski, Dario Dornbierer, Erich Seifritz, Franz X. Vollenweider, Milan Scheidegger
Scientific Reports March 26, 2024 DOI: 10.1038/s41598-024-55726-x (opens in new tab)
The journal has published a correction to this paper. Read the correction (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Randomized controlled trial Peer reviewed |
|---|---|
| Sample size | 36 |
| Population | Experienced meditators |
| Interventions | Psilocybin Placebo |
| Duration | Five-day retreat |
| Topics | Meditation Psilocybin |
| Keywords | Psychedelics Consciousness Self-awareness |
| Citations | 15 |
| Key findings | Psilocybin-induced positive derealization linked to open-monitoring meditation was associated with greater optimal transport distance between open-monitoring and resting-state brain activity, suggesting enhanced meta-awareness and insight. |
Abstract
In this study, for the first time, we explored a dataset of functional magnetic resonance images collected during focused attention and open monitoring meditation before and after a five-day psilocybin-assisted meditation retreat using a recently established approach, based on the Mapper algorithm from topological data analysis. After generating subject-specific maps for two groups (psilocybin vs. placebo, 18 subjects/group) of experienced meditators, organizational principles were uncovered using graph topological tools, including the optimal transport (OT) distance, a geometrically rich measure of similarity between brain activity patterns. This revealed characteristics of the topology (i.e. shape) in space (i.e. abstract space of voxels) and time dimension of whole-brain activity patterns during different styles of meditation and psilocybin-induced alterations. Most interestingly, we found that (psilocybin-induced) positive derealization, which fosters insightfulness specifically when accompanied by enhanced open-monitoring meditation, was linked to the OT distance between open-monitoring and resting state. Our findings suggest that enhanced meta-awareness through meditation practice in experienced meditators combined with potential psilocybin-induced positive alterations in perception mediate insightfulness. Together, these findings provide a novel perspective on meditation and psychedelics that may reveal potential novel brain markers for positive synergistic effects between mindfulness practices and psilocybin.
Comparable studies
Other randomized controlled trials on psilocybin and meditation, most cited first.
Citations in the library
Cited by 15
- Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat Journal of Psychopharmacology September 27, 2024
- Mechanisms of psilocybin on the treatment of posttraumatic stress disorder Journal of Psychopharmacology October 3, 2024
- Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans. Neuroscience & Biobehavioral Reviews August 1, 2025
- Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial PLoS Medicine September 19, 2025
- Metacognitive Feelings of Epistemic Gain are Central to the Understanding of Psychedelic-Induced Mystical-Type Experiences Cognitive Therapy and Research March 29, 2025
and 10 more in the library
Cites 67
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Mind the Hype: A Critical Evaluation and Prescriptive Agenda for Research on Mindfulness and Meditation Perspectives on Psychological Science October 10, 2017
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder JAMA Psychiatry November 4, 2020
and 62 more in the library